UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004819
Receipt number R000005737
Scientific Title Phase II trial of trastumab and weekly paclitaxel for breast cancer. -Japan Breast Cancer Research Network (JBCRN) Trial
Date of disclosure of the study information 2011/02/01
Last modified on 2011/07/05 09:04:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Phase II trial of trastumab and weekly paclitaxel for breast cancer.
-Japan Breast Cancer Research Network (JBCRN) Trial

Acronym

trastumab and weekly paclitaxel for breast cancer.

Scientific Title

Phase II trial of trastumab and weekly paclitaxel for breast cancer.
-Japan Breast Cancer Research Network (JBCRN) Trial

Scientific Title:Acronym

trastumab and weekly paclitaxel for breast cancer.

Region

Japan


Condition

Condition

Metastatic breast cancer

Classification by specialty

Breast surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To estimate the efficacy of abraxane and weekly paclitaxel combination therapy

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Phase II


Assessment

Primary outcomes

response

Key secondary outcomes

safety


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

abraxane and paclitaxel

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

1 Patient should be daignose metastatic breast cancer
2 The metastatic size should be more than 10 mmm.

Key exclusion criteria

1) Patient had already treated with palitaxel or trastumab.
2) anaphyaxy of durg
3) pregnant condition

Target sample size

25


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name dago yamamoto

Organization

kansai Medical University

Division name

surgery

Zip code


Address

2-3-1

TEL

02-804-0101

Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

kansai meical university

Division name

surgery

Zip code


Address

2-3-1 shinmachi, hirakata-city, Osaka, Japan

TEL


Homepage URL


Email



Sponsor or person

Institute

Japan Breast Cancer Research Network (JBCRN)

Institute

Department

Personal name



Funding Source

Organization

Japan Breast Cancer Research Network (JBCRN)

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

関西医科大学病院


Other administrative information

Date of disclosure of the study information

2011 Year 02 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2011 Year 07 Month 01 Day

Date of IRB


Anticipated trial start date

2011 Year 07 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 01 Month 04 Day

Last modified on

2011 Year 07 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005737


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name